Christopher James Frankenfield - Net Worth and Insider Trading

Christopher James Frankenfield Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Christopher James Frankenfield owns 1 companies in total, including Xilio Therapeutics Inc (XLO) .

Click here to see the complete history of Christopher James Frankenfield’s form 4 insider trades.

Insider Ownership Summary of Christopher James Frankenfield

Ticker Comapny Transaction Date Type of Owner
XLO Xilio Therapeutics Inc 2023-08-03 Chief Operating Officer

Christopher James Frankenfield Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Christopher James Frankenfield Ownership Network

Ownership Network List of Christopher James Frankenfield

No Data

Ownership Network Relation of Christopher James Frankenfield

Insider Network Chart

Christopher James Frankenfield Owned Company Details

What does Xilio Therapeutics Inc do?

Who are the key executives at Xilio Therapeutics Inc?

Christopher James Frankenfield is the Chief Operating Officer of Xilio Therapeutics Inc. Other key executives at Xilio Therapeutics Inc include 10 percent owner Atlas Venture Fund Xi, L.p. , Chief Medical Officer Katarina Luptakova , and SVP & FINANCE AND ACCOUNTING Kevin M. Brennan .

Xilio Therapeutics Inc (XLO) Insider Trades Summary

Over the past 18 months, Christopher James Frankenfield made no insider transaction in Xilio Therapeutics Inc (XLO). Other recent insider transactions involving Xilio Therapeutics Inc (XLO) include a net sale of 5,235 shares made by Atlas Venture Fund Xi, L.p. , and a net purchase of 485,250 shares made by Gilead Sciences Inc .

In summary, during the past 3 months, insiders sold 0 shares of Xilio Therapeutics Inc (XLO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 5,235 shares of Xilio Therapeutics Inc (XLO) were sold and 485,250 shares were bought by its insiders, resulting in a net purchase of 480,015 shares.

Xilio Therapeutics Inc (XLO)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Xilio Therapeutics Inc Insider Transactions

No Available Data

Christopher James Frankenfield Mailing Address

Above is the net worth, insider trading, and ownership report for Christopher James Frankenfield. You might contact Christopher James Frankenfield via mailing address: C/o Xilio Therapeutics, Inc., 828 Winter Street, Waltham Ma 02451.

Discussions on Christopher James Frankenfield

No discussions yet.